Generation of an induced pluripotent stem cell line, FJMUUHi001-A, from a hereditary Parkinson's disease patient with homozygous mutation of c.189dupA in PARK7

被引:1
|
作者
Chen, Zhi-Ting [1 ,2 ]
Zhao, Zhen-Hua [2 ,3 ]
Chen, Li-Na [1 ,2 ]
Fan, Fei [4 ]
Cai, Guo-En [1 ,2 ]
Weng, Hui-Dan [1 ,2 ]
Wang, Ying-Qing [1 ,2 ]
Liao, Lian-Ming [5 ]
Chen, Xiao-Chun [2 ]
Huang, En [6 ]
Ye, Qin-Yong [1 ,2 ]
机构
[1] Fujian Med Univ, Fujian Inst Geriatr, Dept Neurol, Union Hosp, Fuzhou 350001, Peoples R China
[2] Fujian Med Univ, Inst Neurosci, Fujian Key Lab Mol Neurol, Fuzhou 350001, Peoples R China
[3] Fujian Med Univ, Shengli Clin Med Coll, Fuzhou 350001, Peoples R China
[4] Fujian Hlth Coll, Fuzhou 350101, Peoples R China
[5] Fujian Med Univ, Ctr Translat Med Hematol, Union Hosp, Fuzhou 350001, Peoples R China
[6] Fujian Med Univ, Sch Basic Med Sci, Fuzhou 350122, Peoples R China
基金
中国国家自然科学基金;
关键词
D O I
10.1016/j.scr.2021.102175
中图分类号
Q813 [细胞工程];
学科分类号
摘要
PARK7 mutations are accountable for the inherited Parkinson's disease. An induced pluripotent stem cell (iPSC) line FJMUUHi001-A was generated by expressing five reprogramming factors, OCT3/4, SOX2, c-MYC, KLF4 and BCL-XL, in peripheral blood mononuclear cells from a 32-year old patient carrying a homozygous mutation of c.189dupA in PARK7. The iPSCs with a normal karyotype had the abilities to differentiate into three germ layers and expressed pluripotency markers without detectable residual plasmids. The cell line FJMUUHi001-A carrying the truncating protein PARK7 could be a useful tool to help comprehend the function of PARK7 in the iPSCs and differentiated cells from them.
引用
收藏
页数:4
相关论文
共 50 条
  • [41] Generation of MERRF patient-derived induced pluripotent stem cell line iMERRF-C7
    Liang, Dong
    Hu, Huanran
    Xu, Tianhui
    Wang, Yan
    Hu, Ping
    Xu, Zhengfeng
    STEM CELL RESEARCH, 2016, 17 (03) : 616 - 618
  • [42] Generation of an induced pluripotent stem cell line (CSC-44) from a Parkinson's disease patient carrying a compound heterozygous mutation (c.823C>T and EX6 del) in the PARK2 gene
    Marote, Ana
    Pomeshchik, Yuriy
    Goldwurm, Stefano
    Collin, Anna
    Lamas, Nuno J.
    Pinto, Luisa
    Salgado, Antonio J.
    Roybon, Laurent
    STEM CELL RESEARCH, 2018, 27 : 90 - 94
  • [43] Generation of integration-free induced pluripotent stem cell line (NJMUi001-A) from a phenylketonuria patient
    Xu, Tianhui
    Liang, Dong
    Zhang, Jingjing
    Ji, Xiuqing
    Hu, Huanran
    Sun, Yun
    Jiang, Tao
    Wang, Xia
    Hu, Ping
    Xu, Zhengfeng
    STEM CELL RESEARCH, 2017, 25 : 179 - 182
  • [44] Generation of an induced pluripotent stem cell line (IUFi001) from a Cockayne syndrome patient carrying a mutation in the ERCC6 gene
    Martins, Soraia
    Hacheney, Inken
    Teichweyde, Nadine
    Hildebrandt, Barbara
    Krutmann, Jean
    Rossi, Andrea
    STEM CELL RESEARCH, 2021, 55
  • [45] Generation of an induced pluripotent stem cell line (SMBCi022-A) from a patient with Fabry disease
    Li, Zihan
    Luan, Jing
    Yang, Yali
    Li, Guowei
    Hu, Zhouhui
    Yu, Che
    Cui, Yazhou
    Han, Jinxiang
    STEM CELL RESEARCH, 2025, 83
  • [46] Generation of an induced pluripotent stem cell line from a patient carrying FBN1/c.6734 G > A mutation
    Pan, Ziwei
    Wang, Hongkun
    Wang, Hao
    Liu, Yong
    Liang, Ping
    STEM CELL RESEARCH, 2021, 55
  • [47] Generation of an induced pluripotent stem cell line (CSC-41) from a Parkinson's disease patient carrying a p.G2019S mutation in the LRRK2 gene
    Marote, Ana
    Pomeshchik, Yuriy
    Collin, Anna
    Goldwurm, Stefano
    Lamas, Nuno J.
    Pinto, Luisa
    Salgado, Antonio J.
    Roybon, Laurent
    STEM CELL RESEARCH, 2018, 28 : 44 - 47
  • [48] Generation of induced pluripotent stem cell line (ZZUi007-A) from a 52-year-old patient with a novel CHCHD2 gene mutation in Parkinson's disease
    Wang, Yanlin
    Wang, Zhilei
    Sun, Huifang
    Mao, Chengyuan
    Yang, Jing
    Liu, Yutao
    Liu, Han
    Zhang, Shoutao
    Zhang, Jin
    Xu, Yuming
    Shi, Changhe
    STEM CELL RESEARCH, 2018, 32 : 87 - 90
  • [49] Generation of a human induced pluripotent stem cell line (CSC-40) from a Parkinson's disease patient with a PINK1 p.Q456X mutation
    Russ, Kaspar
    Marote, Ana
    Savchenko, Ekaterina
    Collin, Anna
    Goldwurm, Stefano
    Pomeshchik, Yuriy
    Roybon, Laurent
    STEM CELL RESEARCH, 2018, 27 : 61 - 64
  • [50] Generation of induced pluripotent stem cell line-NTUHi001-A from a premature ovarian failure patient with Turner's syndrome mosaicism
    Lu, Chen-Yu
    Chen, Yu-An
    Syu, Shih-Han
    Lu, Huai-En
    Ho, Hong-Nerng
    Chen, Hsin-Fu
    STEM CELL RESEARCH, 2019, 37